Chloroquine-d5 (diphosphate)

CAT: 0804-HY-17589SSize: 500 µgDry Ice: NoHazardous: No
CAT#:0804-HY-17589SSize:500 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Chloroquine-d5 (diphosphate) is the deuterium labeled Chloroquine (phosphate) . Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine phosphate is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine phosphate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM) [1][2][3][4].
CAS Number
[1854126-42-3]
UNSPSC
12352005
Target
Antibiotic; Autophagy; HIV; Isotope-Labeled Compounds; Parasite; SARS-CoV; Toll-like Receptor (TLR)
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Autophagy; Immunology/Inflammation; Others
Field of Research
Cancer; Infection; Inflammation/Immunology
Solubility
10 mM in DMSO
Smiles
CC(NC1=CC=NC2=CC(Cl)=CC=C12)CCCN(CC)C([2H])([2H])C([2H])([2H])[2H].O=P(O)(O)O.O=P(O)(O)O
Molecular Formula
C18H27D5ClN3O8P2
Molecular Weight
520.89
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Said A, et al. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014 Dec 15;193 (12) :6135-43.|[3]Tuomela J, et al. Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer. Oncol Lett. 2013 Dec;6 (6) :1665-1672.|[4]Mohamed FE, et al. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 2014 Jul 2. doi: 10.1111/liv.12626.|[5]Wang M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30 (3) :269-271.|[6]Colson P, et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55 (4) :105932.|[7]Savarino A, et al. The anti-HIV-1 activity of chloroquine. J Clin Virol. 2001;20 (3) :131-135.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
Plasmodium

Related Products

CatalogName
HY-17589AS-01Chloroquine-d5
HY-135811A-01Desethyl chloroquine (diphosphate)
HY-135811S1-01Desethyl chloroquine-d5
HY-135811AR-01Desethyl chloroquine (diphosphate) (Standard)
HY-17589A-01Chloroquine
HY-W614112(-) -Chloroquine
HY-156862(+) -Chloroquine
HY-135811Desethyl chloroquine
HY-17589AR-01Chloroquine (Standard)
HY-100662-01Didesethyl chloroquine

Alternative Products

CatalogName
TRC-H905303-25MG(R)-(-)-Hydroxy Chloroquine-d5 Diphosphate
TRC-H905308-25MG(S)-(+)-Hydroxy Chloroquine-d5 Diphosphate
465168-01S- (+) -Hydroxy Chloroquine-d5 Diphosphate
463560-01(R) - (-) -Hydroxy Chloroquine-d5 Diphosphate
1825-500Chloroquine Diphosphate
10-018Chloroquine . diphosphate
TRC-C379965-50MGChloroquine Diphosphate Salt
MF-0000202Desethyl chloroquine diphosphate
MF-0101798-01Chloroquine-d5

Popular Products